Meeting
2024 ASCO Genitourinary Cancers Symposium
Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study.
Authors
Heather H. Cheng
Division of Hematology & Oncology, University of Washington & Fred Hutchinson Cancer Center, Seattle, WA
Heather H. Cheng , Kristin Follmer , Claire Marie de la Calle , Chenee Holcomb , Daniel Lee , Michael A. Liss , Kara Noelle Maxwell , Lisa F Newcomb , Yaw A. Nyame , Sarah P. Psutka , Alexandra Sokolova , Erika Wolff , Jonathan L. Wright , Daniel W. Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Clinical Trial Registration Number
NCT04472338
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr TPS357)
DOI
10.1200/JCO.2024.42.4_suppl.TPS357
Abstract #
TPS357
Poster Bd #
R9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
First Author: Anna Couvillon
Poster
2015 Genitourinary Cancers Symposium
A first catch, non-DRE urine exosome gene signature to predict Gleason 7 prostate cancer on an initial prostate needle biopsy.
First Author: Michael J. Donovan
Poster
2015 Genitourinary Cancers Symposium
Prostate-specific antigen velocity as a predictive biomarker in a prospective prostate cancer screening study (IMPACT study).
First Author: Christos Mikropoulos
Poster
2014 Genitourinary Cancers Symposium
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study.
First Author: Christos Mikropoulos